These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1976438)

  • 21. The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?
    van Kampen J; Stoessl AJ
    Neuropharmacology; 1997; 36(11-12):1679-88. PubMed ID: 9517439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
    Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
    Lavigne GJ; Millington WR; Mueller GP
    Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
    Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
    Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
    Kawabata S; Kanayama S; Shinomura Y; Miyazaki Y; Imamura I; Moriwaki K; Wada H; Tarui S
    Regul Pept; 1991 Jul; 35(1):1-10. PubMed ID: 1924892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.
    Hernando F; Fuentes JA; Ruiz-Gayo M
    Br J Pharmacol; 1996 May; 118(2):400-6. PubMed ID: 8735644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
    Derrien M; Noble F; Maldonado R; Roques BP
    Neurosci Lett; 1993 Oct; 160(2):193-6. PubMed ID: 8247353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey.
    O'Neill MF; Dourish CT; Tye SJ; Iversen SD
    Brain Res; 1990 Nov; 534(1-2):287-90. PubMed ID: 2073589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.
    Hill DR; Woodruff GN
    Brain Res; 1990 Sep; 526(2):276-83. PubMed ID: 2257485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
    Roche S; Gusdinar T; Bali JP; Magous R
    Biochem Pharmacol; 1991 Jul; 42(4):771-6. PubMed ID: 1714276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular design of potent specific antagonists for the gastrin and cholecystokinin receptors.
    Evans BE
    Z Gastroenterol Verh; 1991 Mar; 26():269-71. PubMed ID: 1714170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
    Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
    Zavros Y; Shulkes A
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys.
    Moran TH; Ameglio PJ; Peyton HJ; Schwartz GJ; McHugh PR
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R620-4. PubMed ID: 8214156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease.
    Boyce S; Rupniak NM; Steventon MJ; Iversen SD
    Neurology; 1990 Jun; 40(6):927-33. PubMed ID: 2140595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.